Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea
Source: SeekingAlpha
2025-06-23 04:50:15 ET
Vertex Pharmaceuticals ( Nasdaq: NASDAQ: VRTX ) and Ono Pharmaceutical ( OTCMKTS: OTCPK:OPHLY ) have announced an exclusive collaboration, for the development and commercialization of Vertex's povetacicept in Japan and South Korea....
Read the full article on Seeking Alpha
For further details see:
Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea
Ono Pharmaceutical Co Ltd ADR
NASDAQ: OPHLY
OPHLY Trading
0.99% G/L:
$4.898 Last:
3,289 Volume:
$4.91 Open:
